307 related articles for article (PubMed ID: 26407873)
21. The presence of erythropoietin receptor in parathyroid cells.
Oztürk M; Ustek D; Akbas F; Kösem M; Abaci N; Alagöl F; Oztürk G; Kotan C
J Endocrinol Invest; 2007 Dec; 30(11):RC35-7. PubMed ID: 18250608
[TBL] [Abstract][Full Text] [Related]
22. Identification of Differential Transcriptional Patterns in Primary and Secondary Hyperparathyroidism.
Sadowski SM; Pusztaszeri M; Brulhart-Meynet MC; Petrenko V; De Vito C; Sobel J; Delucinge-Vivier C; Kebebew E; Regazzi R; Philippe J; Triponez F; Dibner C
J Clin Endocrinol Metab; 2018 Jun; 103(6):2189-2198. PubMed ID: 29659895
[TBL] [Abstract][Full Text] [Related]
23. Reticulin staining pattern in the differential diagnosis of benign parathyroid lesions.
Kuşku Çabuk F; Sar M; Canoğlu D; Dural C; Güneş ME
J Endocrinol Invest; 2020 Nov; 43(11):1571-1576. PubMed ID: 32242287
[TBL] [Abstract][Full Text] [Related]
24. Galectin-3 and Ki-67 expression in multiglandular parathyroid lesions.
Saggiorato E; Bergero N; Volante M; Bacillo E; Rosas R; Gasparri G; Orlandi F; Papotti M
Am J Clin Pathol; 2006 Jul; 126(1):59-66. PubMed ID: 16753595
[TBL] [Abstract][Full Text] [Related]
25. Expression of cellular retinol- and retinoic acid-binding proteins in normal and pathologic human parathyroid glands.
Melhus H; Li Q; Nordlinder H; Farnebo LO; Grimelius L
Endocr Pathol; 2001; 12(4):423-7. PubMed ID: 11914476
[TBL] [Abstract][Full Text] [Related]
26. Alterations in the suppressor gene PPP2R1B in parathyroid hyperplasias and adenomas.
Hemmer S; Wasenius VM; Haglund C; Zhu Y; Knuutila S; Franssila K; Joensuu H
Cancer Genet Cytogenet; 2002 Apr; 134(1):13-7. PubMed ID: 11996789
[TBL] [Abstract][Full Text] [Related]
27. Parathyroid hormone content distinguishes true normal parathyroids from parathyroids of patients with primary hyperparathyroidism.
Weber CJ; Russell J; Chryssochoos JT; Hagler M; McGarity WC
World J Surg; 1996 Oct; 20(8):1010-4; discussion 1014-5. PubMed ID: 8798358
[TBL] [Abstract][Full Text] [Related]
28. Flow cytometric DNA analysis of parathyroid glands. Relationship between nuclear DNA and pathologic classifications.
Bowlby LS; DeBault LE; Abraham SR
Am J Pathol; 1987 Aug; 128(2):338-44. PubMed ID: 3618729
[TBL] [Abstract][Full Text] [Related]
29. The role of hyperplasia in multiple parathyroid adenomas.
Larian B; Alavi S; Roesler J; Namazie A; Blackwell K; Calcaterra TC; Wang MB
Head Neck; 2001 Feb; 23(2):134-9. PubMed ID: 11303630
[TBL] [Abstract][Full Text] [Related]
30. A histological comparison of adenomatous and hyperplastic parathyroid glands.
Lawrence DA
J Clin Pathol; 1978 Jul; 31(7):626-32. PubMed ID: 670416
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory infiltrates in parathyroid tumors.
Haglund F; Hallström BM; Nilsson IL; Höög A; Juhlin CC; Larsson C
Eur J Endocrinol; 2017 Dec; 177(6):445-453. PubMed ID: 28855268
[TBL] [Abstract][Full Text] [Related]
32. Identification of differentially expressed microRNA in parathyroid tumors.
Rahbari R; Holloway AK; He M; Khanafshar E; Clark OH; Kebebew E
Ann Surg Oncol; 2011 Apr; 18(4):1158-65. PubMed ID: 21086055
[TBL] [Abstract][Full Text] [Related]
33. Expression of PRAD1/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma.
Tominaga Y; Tsuzuki T; Uchida K; Haba T; Otsuka S; Ichimori T; Yamada K; Numano M; Tanaka Y; Takagi H
Kidney Int; 1999 Apr; 55(4):1375-83. PubMed ID: 10201002
[TBL] [Abstract][Full Text] [Related]
34. A comparative study of p53 immunoexpression in parathyroid hyperplasias secondary to uremia, primary hyperplasias, adenomas and carcinomas.
Kayath MJ; Martin LC; Vieira JG; Roman LM; Nosé-Alberti V
Eur J Endocrinol; 1998 Jul; 139(1):78-83. PubMed ID: 9703382
[TBL] [Abstract][Full Text] [Related]
35. Nodular Leydig cell hyperplasia in a boy with familial male-limited precocious puberty.
Leschek EW; Chan WY; Diamond DA; Kaefer M; Jones J; Barnes KM; Cutler GB
J Pediatr; 2001 Jun; 138(6):949-51. PubMed ID: 11391350
[TBL] [Abstract][Full Text] [Related]
36. Increased protein kinase A type Iα regulatory subunit expression in parathyroid gland adenomas of patients with primary hyperparathyroidism.
Hibi Y; Kambe F; Imai T; Ogawa K; Shimizu Y; Shibata M; Kagawa C; Mizuno Y; Ito A; Iwase K
Endocr J; 2013; 60(2):215-23. PubMed ID: 23197043
[TBL] [Abstract][Full Text] [Related]
37. Nuclear DNA content, S-phase fraction analysis and expression of proliferating cell nuclear antigen (PCNA) of normal and hyperplastic/neoplastic parathyroid glands.
Suzuki S; Tsuchiya A; Hara K; Abe R
Fukushima J Med Sci; 1997 Jun; 43(1):41-50. PubMed ID: 9431783
[TBL] [Abstract][Full Text] [Related]
38. DNA index and ploidy distinguish normal human parathyroids from parathyroid adenomas and primary hyperplastic parathyroids.
Chryssochoos JT; Weber CJ; Cohen C; Moore J; DeRose PB; Hagler M; Bray R; Stempora L; Mainiero M; McGarity WC
Surgery; 1995 Dec; 118(6):1041-9; discussion 1049-50. PubMed ID: 7491521
[TBL] [Abstract][Full Text] [Related]
39. Expression of transcripts encoding a parathyroid hormone-related peptide in abnormal human parathyroid tissues.
Ikeda K; Arnold A; Mangin M; Kinder B; Vydelingum NA; Brennan MF; Broadus AE
J Clin Endocrinol Metab; 1989 Dec; 69(6):1240-8. PubMed ID: 2573615
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical detection of cell cycle regulators, Fhit protein and apoptotic cells in parathyroid lesions.
Thomopoulou GE; Tseleni-Balafouta S; Lazaris AC; Koutselini H; Kavantzas N; Davaris PS
Eur J Endocrinol; 2003 Jan; 148(1):81-7. PubMed ID: 12534361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
